Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Midgut Neuroendocrine Tumor”

14 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 14 results

Large-scale testing (Phase 3)Study completedNCT00171873
What this trial is testing

Antiproliferative Effect of Octreotide in Patients With Metastasized Neuroendocrine Tumors of the Midgut

Who this might be right for
Neuroendocrine Tumors
Carmen Schade-Brittinger 85
Large-scale testing (Phase 3)Study completedNCT01578239
What this trial is testing

A Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours

Who this might be right for
Carcinoid Tumor of the Small BowelNeuroendocrine Tumour
Advanced Accelerator Applications 231
Testing effectiveness (Phase 2)Active Not RecruitingNCT03891784
What this trial is testing

Abemaciclib in Treating Patients With Advanced, Refractory, and Unresectable Digestive System Neuroendocrine Tumors

Who this might be right for
Advanced Digestive System Neuroendocrine NeoplasmDigestive System Neuroendocrine TumorForegut Neuroendocrine Tumor+6 more
University of Washington 20
Testing effectiveness (Phase 2)Study completedNCT02358356
What this trial is testing

Capecitabine ON Temozolomide Radionuclide Therapy Octreotate Lutetium-177 NeuroEndocrine Tumours Study

Who this might be right for
Midgut Neuroendocrine TumoursPancreatic Neuroendocrine Tumours
Australasian Gastro-Intestinal Trials Group 75
Not applicableStudy completedNCT03667092
What this trial is testing

Exploration of Molecular Biomarkers for Lu-177 DOTATATE Therapy in Midgut Neuroendocrine Tumor

Who this might be right for
Midgut Neuroendocrine Tumors
University Hospital, Toulouse 47
Not applicableLooking for participantsNCT04735198
What this trial is testing

Prophylactic Cholecystectomy in Midgut NETs Patients Who Require Primary Tumor Surgery.

Who this might be right for
Midgut Carcinoid TumorBiliary Stones
Hospital Universitari de Bellvitge 100
Testing effectiveness (Phase 2)UnknownNCT01731925
What this trial is testing

Sunitinib Versus Placebo in Combination With Lanreotide in Patients With Progressive Advanced/Metastatic Midgut Carcinoid Tumors

Who this might be right for
Carcinoid Tumors
GERCOR - Multidisciplinary Oncology Cooperative Group 44
Post-approval studies (Phase 4)Study completedNCT02075606
What this trial is testing

Circulating Tumour Cells in Somatuline Autogel Treated NeuroEndocrine Tumours Patients

Who this might be right for
NeuroEndocrine Tumours
Ipsen 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT01841736
What this trial is testing

Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors

Who this might be right for
Foregut Neuroendocrine TumorHindgut Neuroendocrine TumorMetastatic Digestive System Neuroendocrine Tumor G1+5 more
National Cancer Institute (NCI) 171
Not applicableUnknownNCT03622333
What this trial is testing

Clinic, Pathologic and Genetic Characterization of Patients With Familial Carcinoid Tumors (Study From the GTE, Groupe d'étude Des Tumeurs Endocrines)

Who this might be right for
Small Intestinal Carcinoid Tumors
CHU de Reims 60
Very early researchActive Not RecruitingNCT03044977
What this trial is testing

Study to Evaluate the Safety of Combining Two Radionuclide Therapies to Treat Mid-gut Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Tumor, MalignantNeuroendocrine Tumor Gastrointestinal, Hormone-Secreting
David Bushnell 20
Testing effectiveness (Phase 2)WithdrawnNCT04614766
What this trial is testing

A Clinical Trial Evaluating the Safety of Combining Lutathera(R) and Azedra(R) to Treat Mid-gut Neuroendocrine Tumors

Who this might be right for
Gastro-enteropancreatic Neuroendocrine TumorNeuroendocrine Tumors
David Bushnell
Large-scale testing (Phase 3)Looking for participantsNCT06878664
What this trial is testing

Randomized Interval Assessment Trial of Lu177-Dotatate in Slowly Progressive G1-2 Advanced Midgut Neuroendocrine Tumors

Who this might be right for
Grade1-2 Advanced Midgut Neuroendocrine Tumors (NETs)
Grupo Espanol de Tumores Neuroendocrinos 166
Testing effectiveness (Phase 2)Study completedNCT02651987
What this trial is testing

Efficacy and Safety Study in Pancreatic or Midgut Neuroendocrine Tumours Having Progressed Radiologically While Previously Treated With Lanreotide Autogel® 120 mg

Who this might be right for
Pancreatic TumoursMidgut Neuroendocrine Tumours
Ipsen 99